Acrivon Therapeutics (ACRV) Earnings Date & Reports
A.I. Advisor
published Earnings
ACRV is expected to report earnings to rise 42.31% to -74 cents per share on November 07
Q3'24
Est.
$-0.74
Q2'24
Beat
by $0.23
Q1'24
Beat
by $0.06
Q4'23
Missed
by $0.14
Q3'23
Beat
by $0.05
The last earnings report on August 13 showed earnings per share of -51 cents, beating the estimate of -75 cents. With 63.74K shares outstanding, the current market capitalization sits at 250.26M.